ACAD
Price
$18.49
Change
+$0.29 (+1.59%)
Updated
Mar 28, 6:59 PM EST
33 days until earnings call
MORF
Price
$35.20
Change
+$0.81 (+2.36%)
Updated
Mar 28, 6:59 PM EST
26 days until earnings call
Ad is loading...

Compare trend and price ACAD vs MORF

Header iconACAD vs MORF Comparison
Open Charts ACAD vs MORFBanner chart's image
ACADIA Pharmaceuticals
Price$18.49
Change+$0.29 (+1.59%)
Volume$955.97K
CapitalizationN/A
Morphic Holding
Price$35.20
Change+$0.81 (+2.36%)
Volume$182.95K
CapitalizationN/A
View a ticker or compare two or three
ACAD vs MORF Comparison Chart

Loading...

ACADDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MORFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ACAD vs. MORF commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and MORF is a Buy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (ACAD: $18.46 vs. MORF: $35.12)
Brand notoriety: ACAD and MORF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 61% vs. MORF: 54%
Market capitalization -- ACAD: $3.04B vs. MORF: $1.76B
ACAD [@Biotechnology] is valued at $3.04B. MORF’s [@Biotechnology] market capitalization is $1.76B. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 0 FA rating(s) are green whileMORF’s FA Score has 0 green FA rating(s).

  • ACAD’s FA Score: 0 green, 5 red.
  • MORF’s FA Score: 0 green, 5 red.
According to our system of comparison, MORF is a better buy in the long-term than ACAD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 4 TA indicator(s) are bullish while MORF’s TA Score has 4 bullish TA indicator(s).

  • ACAD’s TA Score: 4 bullish, 4 bearish.
  • MORF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MORF is a better buy in the short-term than ACAD.

Price Growth

ACAD (@Biotechnology) experienced а +0.27% price change this week, while MORF (@Biotechnology) price change was +1.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

ACAD is expected to report earnings on May 01, 2024.

MORF is expected to report earnings on Apr 24, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ACAD with price predictions.
OPEN
A.I.dvisor published
a Summary for MORF with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ACAD($3.04B) has a higher market cap than MORF($1.76B). MORF YTD gains are higher at: 21.607 vs. ACAD (-41.041). ACAD has higher annual earnings (EBITDA): -67.83M vs. MORF (-177.6M). MORF has more cash in the bank: 704M vs. ACAD (439M). MORF has less debt than ACAD: MORF (2.34M) vs ACAD (57.2M). ACAD has higher revenues than MORF: ACAD (726M) vs MORF (521K).
ACADMORFACAD / MORF
Capitalization3.04B1.76B173%
EBITDA-67.83M-177.6M38%
Gain YTD-41.04121.607-190%
P/E RatioN/AN/A-
Revenue726M521K139,347%
Total Cash439M704M62%
Total Debt57.2M2.34M2,440%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADMORF
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
ACADDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MORFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLARX8.100.07
+0.89%
MainStay CBRE Real Estate A
BAFMX15.86N/A
N/A
Brown Advisory Mid-Cap Growth Instl
MAEGX14.53-0.01
-0.07%
BlackRock Unconstrained Equity Instl
RTNCX11.42-0.02
-0.17%
Russell Inv Tax-Managed Intl Eq C
VDIPX25.20-0.06
-0.24%
Vanguard Developed Markets Index Ins Pls

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with VRTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
+1.43%
VRTX - ACAD
43%
Loosely correlated
+0.17%
DNLI - ACAD
40%
Loosely correlated
-1.30%
STTK - ACAD
40%
Loosely correlated
-0.22%
FOLD - ACAD
40%
Loosely correlated
-0.93%
VRDN - ACAD
39%
Loosely correlated
N/A
More

MORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MORF has been loosely correlated with ORMP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MORF jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MORF
1D Price
Change %
MORF100%
+2.12%
ORMP - MORF
45%
Loosely correlated
+3.55%
AXON - MORF
43%
Loosely correlated
-0.98%
ARRY - MORF
42%
Loosely correlated
-1.26%
SRPT - MORF
42%
Loosely correlated
-0.57%
PCVX - MORF
41%
Loosely correlated
-0.39%
More